Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Woolf Tod — RXI PHARMACEUTICALS CORP insider: 2 transactions · InsiderLens

Home / Insiders / Woolf Tod

Woolf Tod

Director at RXI PHARMACEUTICALS CORP · on record since Feb 14, 2008
President and CEO at RXI PHARMACEUTICALS CORP · on record since Feb 14, 2008

Insider trading activity of Woolf Tod

Transactions on record: 2; since Apr 22, 2008

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 20, 2009

Figures computed from official regulatory filings — methodology.

Companies where Woolf Tod has traded

RXI PHARMACEUTICALS CORP2 tx · Jan 20, 2009

Track record of Woolf Tod

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Woolf Tod

Co-insiders of Woolf Tod

Advanced RNA Technologies, LLCRXI PHARMACEUTICALS CORP
Ahn Mark JRXI PHARMACEUTICALS CORP
Andrikopoulos KonstantinosRXI PHARMACEUTICALS CORP
Ashton WilliamRXI PHARMACEUTICALS CORP
Barrett John ARXI PHARMACEUTICALS CORP
Beerman Noah DRXI PHARMACEUTICALS CORP
Bitterman Robert JRXI PHARMACEUTICALS CORP

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BRADFORD PATRICIA ARXI PHARMACEUTICALS CORP

Brownlie Keith LRXI PHARMACEUTICALS CORP

Burns John ThomasRXI PHARMACEUTICALS CORP

Carson Lisa CabottRXI PHARMACEUTICALS CORP

CAUWENBERGH GEERTRXI PHARMACEUTICALS CORP

Chin RichardRXI PHARMACEUTICALS CORP

CYTRX CORPRXI PHARMACEUTICALS CORP

Deming David HRXI PHARMACEUTICALS CORP

DiPalma Stephen J.RXI PHARMACEUTICALS CORP

Dispersyn GerritRXI PHARMACEUTICALS CORP

Dorman H. PaulRXI PHARMACEUTICALS CORP

Dunlap RyanRXI PHARMACEUTICALS CORP

Einhorn Irving M.RXI PHARMACEUTICALS CORP

Eliseev AlexeyRXI PHARMACEUTICALS CORP

Ferrara Robert LRXI PHARMACEUTICALS CORP

Freeman Jonathan ERXI PHARMACEUTICALS CORP

Galena Biopharma, Inc.RXI PHARMACEUTICALS CORP

GALLIKER STEPHEN SRXI PHARMACEUTICALS CORP

Gerber SanderRXI PHARMACEUTICALS CORP

Ghiglieri Stephen FRXI PHARMACEUTICALS CORP

GRAY MARY ANNRXI PHARMACEUTICALS CORP

Hamilton Brian LRXI PHARMACEUTICALS CORP

Hillsberg SanfordRXI PHARMACEUTICALS CORP

Hudson Bay Capital Management, L.P.RXI PHARMACEUTICALS CORP

Infarinato Robert M.RXI PHARMACEUTICALS CORP

Kennedy Robert EugeneRXI PHARMACEUTICALS CORP

Khvorova AnastasiaRXI PHARMACEUTICALS CORP

Kivinski MargaretRXI PHARMACEUTICALS CORP

Knapp Thomas JRXI PHARMACEUTICALS CORP

Kontulis CaitlinRXI PHARMACEUTICALS CORP

KRIEGSMAN STEVEN ARXI PHARMACEUTICALS CORP

Lee KwangRXI PHARMACEUTICALS CORP

Lockshin CurtisRXI PHARMACEUTICALS CORP

MAZANET ROSEMARYRXI PHARMACEUTICALS CORP

Nejadnik BijanRXI PHARMACEUTICALS CORP

Nisi RudolphRXI PHARMACEUTICALS CORP

Opko Health, Inc.RXI PHARMACEUTICALS CORP

Pavco PamelaRXI PHARMACEUTICALS CORP

Samarsky DmitryRXI PHARMACEUTICALS CORP

SCHWARTZ MARK W.RXI PHARMACEUTICALS CORP

Tata Amy BRXI PHARMACEUTICALS CORP

Varanasi RamaniRXI PHARMACEUTICALS CORP

Company	Filed	Type	Qty	Price	Value · USD	Src
RXI PHARMACEUTICALS CORP	Jan 20, 2009	AwardD	48,000	0.00	$0	SEC
RXI PHARMACEUTICALS CORP	Apr 22, 2008	AwardD	55,106	0.00	$0	SEC